PWP
GILD icon

Phillips Wealth Planners’s Gilead Sciences GILD Stock Holding History

Phillips Wealth Planners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$470K Sell
3,450
-26
-0.7% -$3.43K 0.35% 87
2026
Q1 		$464K Sell
3,476
-432
-11% -$60.5K 0.35% 92
2025
Q4 		$505K Buy
3,908
+1,630
+72% +$198K 0.4% 79
2025
Q3 		$259K Sell
2,278
-421
-16% -$47.9K 0.21% 165
2025
Q2 		$300K Sell
2,699
-673
-20% -$71.6K 0.27% 131
2025
Q1 		$349K Sell
3,372
-799
-19% -$82.4K 0.37% 91
2024
Q4 		$375K Sell
4,171
-511
-11% -$46K 0.37% 85
2024
Q3 		$406K Buy
4,682
+193
+4% +$14.7K 0.39% 87
2024
Q2 		$309K Buy
4,489
+520
+13% +$34.7K 0.33% 114
2024
Q1 		$267K Buy
3,969
+999
+34% +$76.8K 0.31% 127
2023
Q4 		$257K Buy
2,970
+130
+5% +$10.1K 0.31% 123
2023
Q3 		$223K Buy
+2,840
New +$218K 0.3% 128
2023
Q2 		– Sell
-2,789
Closed -$227K – 151
2023
Q1 		$227K Sell
2,789
-1,284
-32% -$106K 0.3% 130
2022
Q4 		$356K Buy
+4,073
New +$323K 0.62% 60

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Phillips Wealth Planners's GILD Position: Q2 2026 in Review

Phillips Wealth Planners reduced its Gilead Sciences (GILD) stake by 0.75% in Q2 2026, selling an estimated $3.43K and leaving 3,450 shares worth $470K. The position accounts for 0.35% of the portfolio, ranked #87.

Phillips Wealth Planners first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $505K in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Phillips Wealth Planners held 3,450 shares of Gilead Sciences worth $470K as of Q2 2026.
  • Phillips Wealth Planners sold 26 Gilead Sciences shares in Q2 2026, an estimated $3.43K.
  • Gilead Sciences made up 0.35% of Phillips Wealth Planners's portfolio in Q2 2026, its #87 holding.
  • Phillips Wealth Planners first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • Phillips Wealth Planners's Gilead Sciences position peaked at $505K in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Phillips Wealth Planners's 13F filing for Q2 2026, filed 7 Aug 2026.